35 results on '"Balmaceda C"'
Search Results
2. EE15 Cost-Effectiveness Evaluation of Human Papilloma Virus Test in Comparison with Cytology in Uruguay from the Public Health System Perspective
3. EE492 Cost-Effectiveness of Dabigatran for Thromboembolic Events Prevention in Atrial Fibrillation Patients
4. EE369 Cost-Effectiveness Analysis of Drug Therapies for Diabetes Mellitus Type 2 in Chile
5. EE264 Predictions on the Health and Economic Effects for the Chilean Population With Type 2 Diabetes Mellitus Recently Diagnosed
6. POSC151 Cost-Effectiveness Analysis of Ribociclib in Ecuadorian Women with Advanced Breast Cancer
7. PCN92 COST-EFFECTIVENESS ANALYSIS OF POLATUZUMAB IN COMBINATION WITH RITUXIMAB AND BEVACIZUMAB FOR THE TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
8. PRS33 EXPECTED VALUE OF INFORMATION AND EXPECTED PARTIAL VALUE OF INFORMATION FOR TRELEGY COMPARED WITH A MULTIPLE INHALER TRIPLE THERAPY (MITT) FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN CHILE
9. PRS34 COST-EFFECTIVENESS ANALYSIS OF A SINGLE-INHALER TRIPLE THERAPY (TRELEGYÑ) VS DUAL COMBINATION AND MULTIPLE-INHALER TRIPLE THERAPY FOR THE TREATMENT OF PATIENTS WITH COPD MODERATE TO VERY-SEVERE.
10. PRS30 BUDGET IMPACT ANALYSIS OF A SINGLE-INHALER TRIPLE THERAPY (TRELEGYÑ) VERSUS DUAL COMBINATION AND MULTIPLE-INHALER TRIPLE THERAPY FOR THE TREATMENT OF PATIENTS WITH COPD MODERATE TO VERY-SEVERE FROM PUBLIC HEALTH SYSTEM PERSPECTIVE IN CHILE
11. PRS24 COST-EFFECTIVENESS OF MEPOLIZUMAB ADD-ON IN THE TREATMENT OF SEVERE EOSINOPHILIC ASTHMA IN CHILE
12. PDG19 COST-EFFECTIVENESS OF OBINUTUZUMAB-CHEMOTHERAPY FOLLOWED BY OBINUTUZUMAB MAINTENANCE COMPARED TO RITUXIMAB-CHEMOTHERAPY FOLLOWED BY RITUXIMAB MAINTENANCE IN A CHILEAN HEALTH PUBLIC SYSTEM SETTING FOR NON-HODGKIN-LYMPHOMA PATIENT’S
13. PBI9 BUDGET IMPACT ANALYSIS OF OBINUTUZUMAB-CHEMOTHERAPY FOLLOWED BY OBINUTUZUMAB MAINTENANCE COMPARED TO RITUXIMAB-CHEMOTHERAPY FOLLOWED BY RITUXIMAB MAINTENANCE IN A CHILEAN HEALTH PUBLIC SYSTEM SETTING FOR NON-HODGKIN-LYMPHOMA PATIENTS
14. PBI10 BUDGET IMPACT ANALYSIS OF MEPOLIZUMAB AS AN ADD-ON THERAPY IN THE TREATMENT OF SEVERE EOSINOPHILIC ASTHMA IN CHILE
15. PND7 COST-EFFECTIVENESS OF CLADRIBINE COMPARED TO NATALIZUMAB, OCRELIZUMAB AND ALEMTUZUMAB FOR THE TREATMENT OF PATIENTS WITH HIGHLY ACTIVE RELAPSING REMITTING MULTIPLE SCLEROSIS IN CHILE
16. PND9 BUDGET IMPACT ANALYSIS OF CLADRIBINE COMPARED TO THE CURRENT COVERAGE SCHEME IN CHILE TO TREAT PATIENTS WITH HIGHLY ACTIVE RELAPSING REMITTING MULTIPLE SCLEROSIS
17. PDB9 ESTUDIO DE COSTOS DE LA HIPOGLICEMIA EN PACIENTES CON DIABETES MELLITUS TIPO 2 DESDE LA PERSPECTIVA DE SALUD PUBLICA DE CHILE
18. PCN22 ESTUDIO DE COSTO EFECTIVIDAD DE RIBOCICLIB/LETROZOL PARA EL TRATAMIENTO DEL CANCER DE MAMA METASTASICO CON RECEPTORES DE HORMONA POSITIVO Y HER-2 NEGATIVO DESDE LA PERSPECTIVA DEL SISTEMA DE SALUD PUBLICO CHILENO
19. PCN21 ESTUDIO DE COSTO EFECTIVIDAD DE NIVOLUMAB PARA EL TRATAMIENTO DE SEGUNDA LINEA DEL CARCINOMA DE CELULAS RENALES METASTASICO DESDE LA PERSPECTIVA DEL SISTEMA DE SALUD PUBLICO CHILENO
20. PCN83 BUDGET IMPACT ANALYSIS OF OSIMERTINIB VERSUS PEMETREXED FOR THE SECOND-LINE TREATMENT OF ADVANCED LUNG CANCER WITH T790M POSITIVE FROM PUBLIC HEALTH PERSPECTIVE IN CHILE
21. PCN79 COST EFFECTIVENESS OF OSIMERTINIB VERSUS CHEMOTHERAPY IN SECOND LINE TREATMENT OF NON SMALL CELL LUNG CANCER WITH EPIDERMAL GROWTH FACTOR AND 790M MUTATION IN CHILEAN HEALTH SYSTEM
22. PIH14 - Relación Entre Los Factores Sociodemográfico, Económicos, Condición Clínica Y La Calidad De Vida Relacionada A Salud: Explorando La Eq-5d Y Eq-Vas En Chile
23. PUK5 - Cost Effectiveness of Peritoneal Dialysis Provision for the Treatment of Chronic Kidney Disease from Public Health Perspective in Chile
24. PSY31 - Estudio De Costo Efectividad Del Factor De Coagulación Recombinante IX Unido A Proteina Fc Para El Tratamiento De La Hemofilia B En Chile
25. PSY29 - Estudio De Costo Efectividad Del Factor De Coagulación Recombinante VIII Unido A Proteina Fc Para El Tratamiento De La Hemofilia A En Chile
26. PCN174 - Cost Effectiveness of Nivolumab for the Treatment of Metastatic Melanoma in Chile
27. PCV109 - Cost Effectiveness of Sacubitril/Valsartan Versus Angiotensin-Converting-Enzyme Inhibitor For The Treatment of Heart Failure From Public Health Perspective in Chile
28. PCV43 - Budget Impact Analysis of Sacubitril/Valsartan Versus Angiotensin-Converting-Enzyme Inhibitor for The Treatment of Heart Failure From Public Health Perspective in Chile
29. PSY89 - Cost Effectiveness of Ruxolitinib Versus Best Available Therapy For The Treatment of Myelofibrosis From Public Health Perspective In Chile
30. PDB43 - COST EFFECTIVENESS OF DAPAGLIFLOZIN/METFORMIN VERSUS GLIBENCLAMIDE/METFORMIN FOR THE TREATMENT OF TYPE 2 DIABETES IN CHILE
31. PHP53 - Estudio de La Implementacion de la Exigencia de Bioequivalencia Sobre el Consumo de Medicamentos Durante Agosto 2009 a Noviembre 2014 en Chile
32. PHP1 - Gasto de Bolsillo en Salud y Medicamentos en Chile: Análisis Comparativo de Los Periodos 1997, 2007 y 2012
33. PSY15 - Nuevas Moléculas Registradas En Chile Durante El Año 2014
34. PIH10 - Evaluacion De Costo-Efectividad De Un Programa De Cuidados Integrales Post-Alta Tipo Hospital De Dia Para Adultos Mayores Comparado Con El Manejo Estandar En El Sistema Publico
35. PCV47 - Expected Cost Of Drug Therapy In Patients With Arterial Hypertension, Diabetes Mellitus And Dyslipidemia In Chile: A Probabilistic AnalysiS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.